Helix BioMedix, Inc. (HXBM)
OTCMKTS · Delayed Price · Currency is USD
2.700
0.00 (0.00%)
At close: Feb 4, 2026
Helix BioMedix Market Cap
Helix BioMedix has a market cap or net worth of $606.71 thousand as of February 12, 2026. Its market cap has decreased by -95.12% in one year.
Market Cap
606.71K
Enterprise Value
n/a
Revenue
2.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.70
Market Cap Chart
Since July 26, 1995, Helix BioMedix's market cap has decreased from 1.59M to 606.71K, a decrease of -61.96%. That is a compound annual growth rate of -3.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 606.71K | 35.00% |
| Dec 31, 2025 | 449.42K | -75.00% |
| Dec 26, 2024 | 1.80M | -76.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipella Pharmaceuticals | 878.42K |
| EV Biologics | 840.53K |
| Altamira Therapeutics | 718.01K |
| Aibotics | 717.45K |
| SQZ Biotechnologies Company | 707.79K |
| Sorrento Therapeutics | 706.83K |
| Bio-Path Holdings | 609.98K |
| Innovation Pharmaceuticals | 528.77K |